Obstetrics and Gynecology Epidemiology Center, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, 221 Longwood Ave, Boston, MA 02115, United States of America; Harvard Medical School, 260 Longwood Avenue, Boston, MA 02115, United States of America; Department of Epidemiology, Harvard School of Public Health, 677 Huntington Ave., Boston, MA 02115, United States of America.
Obstetrics and Gynecology Epidemiology Center, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, 221 Longwood Ave, Boston, MA 02115, United States of America.
Gynecol Oncol. 2021 Apr;161(1):282-290. doi: 10.1016/j.ygyno.2021.01.011. Epub 2021 Jan 24.
In women with ovarian cancer, tumor features largely determine serum HE4 and CA125 levels, but non-tumor factors may also influence levels and be better understood by studying determinants in a well-characterized sample of women without cancer.
Serum HE4 and CA125 were measured in 2302 women from the 2001-2002 cohort of the National Heath and Nutritional Survey (NHANES). Publicly-available data on this cohort included demographic/reproductive variables, blood counts, and measurements of C-reactive protein (CRP), total homocysteine (tHcy), cotinine, and creatinine which were examined as predictors of HE4 and CA125 using multivariate models and correlational analyses.
HE4 increased non-linearly by age and current smokers had higher HE4. CA125 was lower in postmenopausal women and non-whites and trended downward with increasing BMI. Current-users of oral contraceptives (OCs) had lower HE4 and CA125; and a downward trend for CA125 was seen with increasing OC use. Pregnant women had higher CA125 and nursing women higher HE4. HE4 and CA125 were positively correlated with neutrophils, monocytes, and the neutrophil-to-lymphocyte ratio and inversely correlated with lymphocytes and the lymphocyte-to-monocyte ratio. CRP was positively correlated with both HE4 and CA125 in postmenopausal women. Strong positive correlations existed for HE4 with both tHcy and creatinine.
Serum levels of HE4 and CA125 are influenced by several hormonal or environmental stimuli which affect non-cancerous tissues normally expressing HE4 or CA125. Cytokine co-expression in those tissues may, in turn, affect white cell counts and account for their correlation with HE4 or CA125 levels.
在卵巢癌患者中,肿瘤特征在很大程度上决定了血清 HE4 和 CA125 水平,但非肿瘤因素也可能影响这些水平,通过研究无癌症的特征明确的女性样本中的决定因素,可以更好地理解这些水平。
在来自 2001-2002 年全国健康和营养调查(NHANES)的 2302 名女性中测量了血清 HE4 和 CA125。该队列的公开数据包括人口统计学/生殖变量、血细胞计数以及 C 反应蛋白(CRP)、总同型半胱氨酸(tHcy)、可替宁和肌酐的测量值,这些数据通过多元模型和相关性分析被用作 HE4 和 CA125 的预测因子。
HE4 随年龄呈非线性增加,当前吸烟者的 HE4 水平更高。绝经后妇女和非白人妇女的 CA125 水平较低,且随着 BMI 的增加呈下降趋势。口服避孕药(OC)的当前使用者的 HE4 和 CA125 水平较低;随着 OC 使用量的增加,CA125 呈下降趋势。孕妇的 CA125 较高,哺乳期妇女的 HE4 较高。HE4 和 CA125 与中性粒细胞、单核细胞和中性粒细胞与淋巴细胞比值呈正相关,与淋巴细胞和淋巴细胞与单核细胞比值呈负相关。CRP 在绝经后妇女中与 HE4 和 CA125 均呈正相关。HE4 与 tHcy 和肌酐均呈强正相关。
HE4 和 CA125 的血清水平受多种影响非癌组织中通常表达 HE4 或 CA125 的激素或环境刺激的影响。这些组织中的细胞因子共同表达可能反过来影响白细胞计数,并解释它们与 HE4 或 CA125 水平的相关性。